Searching map area
A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1
? TBD
scientific article published on 01 August 2019
Nobody has rated this yet. Be the first!
Lists 0